These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
419 related articles for article (PubMed ID: 16935845)
1. Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression. Roth JD; Hughes H; Kendall E; Baron AD; Anderson CM Endocrinology; 2006 Dec; 147(12):5855-64. PubMed ID: 16935845 [TBL] [Abstract][Full Text] [Related]
3. Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats. Roth JD; Trevaskis JL; Wilson J; Lei C; Athanacio J; Mack C; Kesty NC; Coffey T; Weyer C; Parkes DG Int J Obes (Lond); 2008 Aug; 32(8):1201-10. PubMed ID: 18560368 [TBL] [Abstract][Full Text] [Related]
4. Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity. Roth JD; Coffey T; Jodka CM; Maier H; Athanacio JR; Mack CM; Weyer C; Parkes DG Endocrinology; 2007 Dec; 148(12):6054-61. PubMed ID: 17761760 [TBL] [Abstract][Full Text] [Related]
5. Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats. Trevaskis JL; Lei C; Koda JE; Weyer C; Parkes DG; Roth JD Obesity (Silver Spring); 2010 Jan; 18(1):21-6. PubMed ID: 19543217 [TBL] [Abstract][Full Text] [Related]
6. Effects of prior or concurrent food restriction on amylin-induced changes in body weight and body composition in high-fat-fed female rats. Roth JD; Hughes H; Coffey T; Maier H; Trevaskis JL; Anderson CM Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1112-7. PubMed ID: 17698985 [TBL] [Abstract][Full Text] [Related]
7. Effects of amylin and bupropion/naltrexone on food intake and body weight are interactive in rodent models. Clapper JR; Athanacio J; Wittmer C; Griffin PS; D'Souza L; Parkes DG; Roth JD Eur J Pharmacol; 2013 Jan; 698(1-3):292-8. PubMed ID: 23178527 [TBL] [Abstract][Full Text] [Related]
8. Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice. Kusakabe T; Ebihara K; Sakai T; Miyamoto L; Aotani D; Yamamoto Y; Yamamoto-Kataoka S; Aizawa-Abe M; Fujikura J; Hosoda K; Nakao K Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E924-31. PubMed ID: 22275759 [TBL] [Abstract][Full Text] [Related]
9. Interactions of amylinergic and melanocortinergic systems in the control of food intake and body weight in rodents. Roth JD; D'Souza L; Griffin PS; Athanacio J; Trevaskis JL; Nazarbaghi R; Jodka C; Athanacio J; Hoyt J; Forood B; Parkes DG Diabetes Obes Metab; 2012 Jul; 14(7):608-15. PubMed ID: 22276636 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of hypothalamic pro-opiomelanocortin (POMC) expression after weaning is associated with hyperphagia-induced obesity in JCR rats overexpressing neuropeptide Y. Diané A; Pierce WD; Russell JC; Heth CD; Vine DF; Richard D; Proctor SD Br J Nutr; 2014 Mar; 111(5):924-32. PubMed ID: 24094067 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight. Mack C; Wilson J; Athanacio J; Reynolds J; Laugero K; Guss S; Vu C; Roth J; Parkes D Am J Physiol Regul Integr Comp Physiol; 2007 Nov; 293(5):R1855-63. PubMed ID: 17855496 [TBL] [Abstract][Full Text] [Related]
12. A selective cannabinoid-1 receptor antagonist, PF-95453, reduces body weight and body fat to a greater extent than pair-fed controls in obese monkeys. Wagner JD; Zhang L; Kavanagh K; Ward GM; Chin JE; Hadcock JR; Auerbach BJ; Harwood HJ J Pharmacol Exp Ther; 2010 Oct; 335(1):103-13. PubMed ID: 20605903 [TBL] [Abstract][Full Text] [Related]
13. Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice. Kowalski TJ; Spar BD; Weig B; Farley C; Cook J; Ghibaudi L; Fried S; O'Neill K; Del Vecchio RA; McBriar M; Guzik H; Clader J; Hawes BE; Hwa J Eur J Pharmacol; 2006 Mar; 535(1-3):182-91. PubMed ID: 16540104 [TBL] [Abstract][Full Text] [Related]
14. Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice. Lee EY; Kim YW; Oh H; Choi CS; Ahn JH; Lee BW; Kang ES; Cha BS; Lee HC Metabolism; 2014 Jun; 63(6):793-9. PubMed ID: 24684824 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of amylin and salmon calcitonin on neuropeptide gene expression in the lateral hypothalamic area and the arcuate nucleus of the rat. Barth SW; Riediger T; Lutz TA; Rechkemmer G Neurosci Lett; 2003 May; 341(2):131-4. PubMed ID: 12686383 [TBL] [Abstract][Full Text] [Related]
16. Influence of high-fat feeding, diet-induced obesity, and hyperamylinemia on the sensitivity to acute amylin. Boyle CN; Rossier MM; Lutz TA Physiol Behav; 2011 Jul; 104(1):20-8. PubMed ID: 21550355 [TBL] [Abstract][Full Text] [Related]